FDA asks food manufacturers and restaurants to cut the salt in their products over the coming 2½ years with the goal of reducing Americans' overall sodium intake by 12%.
, the country's No. 1 killer. Reducing sodium in the diet ultimately"would have a major impact on hypertension, heart disease and stroke," she said.. That equates to about one teaspoon of table salt..
But experts said that the federal push may increase the likelihood that most major manufacturers will indeed act. In a statement, the National Restaurant Association said it has worked with the FDA on the new guidance and"continues to provide options to address customers' desires and health needs."The president of the American Heart Association, Dr. Donald Lloyd-Jones, said it was"an incredibly exciting moment" that is expected to help people achieve healthier levels of sodium in their diets. That in turn could reduce the risk of heart attacks and strokes, he said.
"There is very little that the average consumer can do," Lurie said."The only way to have a significant impact on sodium intake is by putting the onus on industry."But the consequences don't begin in the heart, Lloyd-Jones said, but rather the kidneys.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
U.S. FDA staff says Moderna did not meet all criteria for COVID-19 boostersScientists at the U.S. Food and Drug Administration said on Tuesday that Moderna Inc had not met all of the agency's criteria to support use of booster doses of its COVID-19 vaccine, possibly because the efficacy of the shot's first two doses has remained strong.
続きを読む »
Merck asks FDA to authorize antiviral Covid pill for emergency useMerck has asked the FDA to authorize its antiviral Covid pill for emergency use. ScottGottliebMD weighs in: 'I think where the government misstepped is that we didn't invest enough in trying to scale up the manufacturing of therapeutics across the board.'
続きを読む »
FDA Staff Don’t Take Position on Moderna Covid-19 BoosterIn an unusual move, FDA staff didn't take a position on Moderna's application for a booster shot, indicating there may be insufficient data to support one
続きを読む »
Merck Seeks FDA Authorization for Antiviral COVID-19 PillDrugmaker Merck announced Monday that it submitted an application to the FDA for emergency use authorization of molnupiravir, an experimental antiviral COVID-19 treatment.
続きを読む »
Merck asks the FDA to authorize use of its promising COVID-19 pillDrugmaker Merck has asked U.S. regulators to authorize its promising pill protecting against COVID-19, setting the stage for a decision within weeks.
続きを読む »
These Popular At-Home Lip Fillers Can Cause Permanent Damage, the FDA WarnsWhy these devices can be so dangerous.
続きを読む »